Tumourigenic characteristics of embryonal carcinoma cells as a model for studying tumour progression of human embryonic stem cells

Cell Proliferation

Volumn 45, Issue 4, 2012, Pages 299-310

  Yang, S ^a,b   Lin, G ^a   Deng, L ^a   Lu, G X ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; APC PROTEIN; BRACHYURY PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; CD9 ANTIGEN; CRIPTO PROTEIN; DNA METHYLTRANSFERASE 3B; FIBROBLAST GROWTH FACTOR 4; LEFTYA PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MYC PROTEIN; NESTIN; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; RAC1 PROTEIN; REX PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 3; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 1; WNT5B PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLASTOCYST; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; ECTODERM; EMBRYO; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; FIBROBLAST; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; WNT SIGNALING PATHWAY;

APOPTOSIS; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, BIOLOGICAL; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84862906584     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2012.00827.x     Document Type: Article

References (26)

1. Gearhart J (1998) New potential for human embryonic stem cells. Science 282, 1061-1062.
2. Rossant J (2007) Stem cells: the magic brew. Nature 448, 260-262.
3. Andrews PW, Damjanov I, Berends J, Kumpf S, Zappavigna V, Mavilio F et al. (1994) Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab. Invest. 71, 243-251.
4. Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R, Wright NA (2003) The new stem cell biology: something for everyone. Mol Pathol. 56, 86-96.
5. Andrews PW, Przyborski SA, Thomson JA (2001) Embryonal Carcinoma Cells as Embryonic Stem Cells. Stem Cell Biology Monograph, 40 Cold Spring Harbor: Cold Spring Laboratory Press.
6. Zeng X, Miura T, Luo Y, Bhattacharya B, Condie B, Chen J et al. (2004) Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem cells 22, 292-312.
7. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317.
8. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K et al. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70.
9. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-{increment}{increment}ct methods. Methods, 25, 402.
10. Mitalipova MM, Rao RR, Hoyer DM, Johnson JA, Meisner LF, Jones KL et al. (2005) Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 23, 19-20.
11. Reya T, Morrison SJ, Clarke MF, Weissman IL (2000) Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
12. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10, 55-63.
13. Ying QL, Nichols J, Chambers I, Smith A (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292.
14. Gat U, DasGupta R, Degenstein L, Fuchs E (1998) De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95, 5-14.
15. Moon RT, Bowerman B, Boutros M, Perrimon N (2002) The promise and perils of Wnt signaling through beta-catenin. Science 296, 1644-1646.
16. Hermann PC, Bhaskar S, Cioffi M, Heeschen C (2010) Cancer stem cells in solid tumors. Semin. Cancer Biol. 20, 77-84.
17. Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J et al. (1996) Comparative analysis of cell surface antigens expressed by cell lines derived from germ cell tumors. Int. J. Cancer 66, 806-816.
18. Draper JS, Pigott C, Thomson JA, Andrews PW (2002) Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200, 249-258.
19. Przyborski SA, Christie VB, Hayman MW, Stewart R, Horrocks GM (2004) Human embryonal carcinoma stem cells: models of embryonic development in humans. Stem Cells Dev. 13, 400-408.
20. Yang S, Lin G, Tan YQ, Zhou D, Deng LY, Cheng DH et al. (2008) Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosom. Cancer 47, 665-679.
21. Almstrup K, Sonne SB, Hoei-Hansen CE, Ottesen AM, Nielsen JE, Skakkebaek NE et al. (2006) From embryonic stem cells to testicular germ cell cancer - should we be concerned? Int. J. Androl. 29, 211-218.
22. Rajpert-De Meyts E (2006) Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Human Reproduction Update 12, 303-323.
23. Andrews PW, Fenderson B, Hakomori S (1987) Human embryonal carcinoma cells and their differentiation in culture. Int. J. Androl. 10, 95-104.
24. Yang S, Lin G, Tan YQ, Deng LY, Yuan D, Lu GX (2010) Differences between karyotypically normal and abnormal human embryonic stem cells. Cell Prolif. 43, 195-206.
25. Derksen PW, Tjin E, Meijer HP, Klok MD, MacGillavry HD, van Oers MH et al. (2004) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci USA 101, 6122-6127.
26. Moon RT, Bowerman B, Boutros M, Perrimon N (2002) The promise and perils of Wnt signaling through b-catenin. Science 296, 1644-1646.